OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine
Nazir Noor, Alexis Angelette, Abby Lawson, et al.
Health psychology research (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 10

Showing 10 citing articles:

Synthesis and clinical application of new drugs approved by FDA in 2023
Yatao Wang, Pengcheng Yang, Yanfeng Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116124-116124
Closed Access | Times Cited: 17

Gepants for Acute and Preventive Migraine Treatment: A Narrative Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1612-1612
Open Access | Times Cited: 38

Crystal growth of Piperazine and a dual approach to electron density mapping and bonding insights
P. Ramesh, S. Israel, P. Rajesh, et al.
Journal of Materials Science Materials in Electronics (2025) Vol. 36, Iss. 6
Closed Access

Nasal spray (Zavegepant) for migraines: a mini-review
Muhammad Omar Larik, Muhammad Ashhal Iftekhar, Bilal Ulhassan Syed, et al.
Annals of Medicine and Surgery (2023) Vol. 85, Iss. 6, pp. 2787-2790
Open Access | Times Cited: 7

Unlocking the potential of luteolin: A natural migraine management approach through network pharmacology
Rapuru Rushendran, Chitra Vellapandian
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 6, pp. 611-621
Open Access | Times Cited: 2

Effects of multiple‐dose administration of zavegepant nasal spray on the single‐dose pharmacokinetics of ethinyl estradiol‐levonorgestrel
Rajinder Bhardwaj, Julie L. Collins, Jennifer Madonia, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 65, Iss. 1, pp. 14-23
Open Access | Times Cited: 2

Safety and Efficacy of Zavegepant in Treating Migraine: A Systematic Review
Zainab Khan, Usman Ahmed, Faizan Shahzad, et al.
Cureus (2023)
Open Access | Times Cited: 6

Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5

Zavegepant Intranasal Spray for Migraines
Amber Lanae Martirosov, Christopher Giuliano, Macy Shupp, et al.
Annals of Pharmacotherapy (2023) Vol. 58, Iss. 8, pp. 827-833
Closed Access | Times Cited: 4

Page 1

Scroll to top